Cognitive effects of creatine ethyl ester supplementation

Behavioural Pharmacology

Volumn 20, Issue 8, 2009, Pages 673-679

  Ling, Jonathan ^a   Kritikos, Minos ^b   Tiplady, Brian ^c  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Creatine ethyl ester; Creatine monohydrate; Human; Intelligence; Memory; Oral supplementation; Reaction time

Indexed keywords

CREATINE; CREATINE ETHYL ESTER; MALTODEXTRIN; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATHLETIC PERFORMANCE; ATTENTION; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; INTELLIGENCE QUOTIENT; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; REACTION TIME; SUPPLEMENTATION; TASK PERFORMANCE;

ADOLESCENT; ATTENTION; COGNITION; CREATINE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTELLIGENCE; MALE; MEMORY; NEUROMUSCULAR DISEASES; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 73949137732     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283323c2a     Document Type: Article

References (23)

1. Amital D, Vishne T, Rubinow A, Levine J (2006). Observed effects of creatine monohydrate in a patient with depression and fibromyalgia. Am J Psychiat 163:1840-1841.
2. Burke DG, Chilibeck PD, Parise G, Tarnopolsky MA, Candow DG (2003). Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration. Int J Sport Nutr Exerc Metabol 13:294-302.
3. Dockree PM, Bellgrove MA, O'Keeffe FM, Moloney P, Aimola L, Carton S, Robertson IH (2005). Sustained attention in traumatic brain injury (tbi) and healthy controls: enhanced sensitivity with dual-task load. Exp Brain Res 168:218-229.
4. Eriksen BA, Eriksen CW (1974). Effects of noise letters upon identification of a target letter in a non-search task. Percept Psychophys 16:143-149.
5. 1H MRS relate to recognition memory. Neurology 55:1874-1883.
6. Fuld JP, Kilduff LP, Neder JA, Pitsiladis Y, Lean MEJ, Ward SA, Cotton MM (2005). Creatine supplementation during pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 60:531-537.
7. Gardiner PT, Heuer MA (2006). Supplemental dietary composition for increasing muscle size and strength. (WO/2006/108295). Patent PCT/CA2006/ 000574: World Intellectual Property Organization.
8. Graham TE, Moisey LL (2006). Caffeine, creatine and food-drug synergy. In: Thompson LU, Ward WE, editors. Food-drug synergy and safety. Boca Raton, FL: CRC Press. pp. 375-410.
9. Item CB, Stockler-Ipsiroglu S, Stromberger C, Muhl A, Alessandri MG, Bianchi MC, et al. (2001). Arginine: glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Hum Genet 69:1127-1133.
10. Jost CR, Van der Zee CEE, in'tZandt HJA, Oerlemans F, Verheil M, Streijger F, et al. (2002). Creatine kinase B-driven energy transfer in the brain is important for habituation and spatial learning behaviour, moss fibre field size and determination of seizure susceptibility. Eur J Neurosci 15:1692-1706.
11. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, et al. (1999). Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5:347-350.
12. Persky AM, Brazeau GA, Hochhaus G (2003a). Pharmacokinetics of the dietary supplement creatine. Clin Pharmacokinet 42:557-574.
13. Persky AM, Müller M, Derendorf H, Grant M, Brazeau GA, Hochhaus G (2003b). Single-and multiple-dose pharmacokinetics of oral creatine. J Clin Pharmacol 43:29-37.
14. Rae C, Digney LA, McEwan RS, Bates CT (2003). Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. P Roy Soc Lond B Bio 270:2147-2150.
15. Raven J, Raven JC, Court JH (1998). Raven manual: standard progressive matrices. Oxford, UK: Oxford, Psychology Press.
16. Schlattner U, Tokarska-Schlattner M, Wallimann T (2006). Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 1762: 164-180.
17. Sternberg S (1975). Memory scanning: new findings and current controversies. Q J Exp Psychol 27:1-32.
18. Stockler S, Holzbach U, Hanefeld F, Marquardt I, Helms G, Requart M, et al. (1994). Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 36:409-413.
19. Stockler S, Hanefeld F, Frahm J (1996). Creatine replacement therapy in guanidinoacetate methyltransferase deficiency: a novel inborn error of metabolism. Lancet 348:789-790. (Pubitemid 26308483)
20. Volek J, Rawson E (2004). Scientific basis and practical aspects of creatine supplementation for athletes. Nutrition 20:609-614.
21. Vorgerd M, Grehl T, Jager M, Muller K, Freitag G, Patzold T, et al. (2000). Creatine therapy in myophosphorylase deficiency (McArdle disease): a placebo-controlled crossover trial. Arch Neurol 57:956-963.
22. Watanabe A, Kato N, Kato T (2002). Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 42:279-285.
23. Wyss M, Schulze A (2002). Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease? Neurosci 112:243-260.